Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03386240Phase 4Terminated
Phase 4, randomised trial in surgical site infection (SSI) (2 arms), sponsored by The University of Texas Medical Branch at Galveston. Primary endpoints: Participants With Endometritis, Wound Infection, or Other Post-Cesarean Infections at 30 days and Participants With Surgical Site Infection at 30 days. Started Jan 2018; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03386240.